Target type: biologicalprocess
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a uropod, a rigid membrane projection with related cytoskeletal components at the trailing edge of a lymphocyte or other cell in the process of migrating or being activated. [GOC:add, ISBN:0781735149, PMID:12714569, PMID:12787750]
Uropod organization is a crucial process in the biology of motile cells, particularly immune cells like neutrophils and macrophages. It refers to the formation of a specialized, tail-like structure at the rear of the cell, which plays a pivotal role in cell migration and immune function.
The formation of the uropod begins as the cell moves forward, driven by actin polymerization and protrusion at the leading edge. As the cell progresses, the trailing edge is retracted, and components of the cytoskeleton, including microtubules, actin filaments, and associated proteins, are redistributed towards the back of the cell. This accumulation of cytoskeletal components forms the basis of the uropod.
The uropod serves several key functions:
1. **Adhesive and signaling platform**: The uropod is enriched with adhesion molecules, such as integrins and selectins, which allow the cell to adhere to the underlying substrate or to other cells. This adhesion provides stability to the cell during migration. Additionally, the uropod acts as a signaling hub, concentrating chemokine receptors and other signaling molecules, which guide the cell's directional movement and contribute to its immune response.
2. **Recycling of membrane components**: As the cell migrates, membrane components that are no longer needed at the leading edge are transported to the uropod and recycled. This ensures efficient membrane turnover and maintains the cell's integrity.
3. **Clearance of debris**: The uropod can also function as a site for the engulfment and clearance of cellular debris or pathogens. This process is particularly important for macrophages, which are responsible for scavenging dead cells and microorganisms.
4. **Directionality and navigation**: The uropod plays a role in determining the direction of cell movement. It can act as a "compass" for the cell, guiding it towards specific targets or areas of interest.
The organization of the uropod is a complex process that involves a cascade of molecular events, including:
* **Actin polymerization and depolymerization**: Actin dynamics are crucial for the formation and retraction of the uropod. Actin filaments are assembled at the leading edge, driving cell movement, and disassembled at the trailing edge, contributing to uropod formation.
* **Microtubule organization**: Microtubules are involved in the transport of components to the uropod and in maintaining its structure. Microtubules extend from the cell's center towards the uropod, providing tracks for vesicle and protein movement.
* **Membrane trafficking**: Vesicles carrying components required for uropod formation, such as adhesion molecules and signaling molecules, are transported to the uropod via microtubules.
* **Signaling cascades**: A complex interplay of signaling pathways regulates the formation and function of the uropod. These pathways include those involving chemokines, integrins, and other cell-cell interactions.
The uropod is a dynamic structure that constantly remodels and reorganizes as the cell moves and interacts with its environment. It plays a crucial role in cell migration, immune cell function, and wound healing, highlighting its significance in various biological processes.'
"
Protein | Definition | Taxonomy |
---|---|---|
Myosin-9 | A myosin-9 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P35579] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
blister | blebbistatin : A pyrroloquinoline that is 1,2,3,3a-tetrahydro-H-pyrrolo[2,3-b]quinolin-4-one substituted by a hydroxy group at position 3a, a methyl group at position 6 and a phenyl group at position 1. It acts as an inhibitor of ATPase activity of non-muscle myosin II. blebbistatin: structure in first source | cyclic ketone; pyrroloquinoline; tertiary alcohol; tertiary alpha-hydroxy ketone | inhibitor |